Cargando…

Onychomycosis: An Updated Review

Background: Onychomycosis is a common fungal infection of the nail. Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis. Methods: A PubMed search was completed in Clinical Queries using the key term “onychomycosis”. The search was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Alexander K.C., Lam, Joseph M., Leong, Kin F., Hon, Kam L., Barankin, Benjamin, Leung, Amy A.M., Wong, Alex H.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509699/
https://www.ncbi.nlm.nih.gov/pubmed/31738146
http://dx.doi.org/10.2174/1872213X13666191026090713
_version_ 1783585650543427584
author Leung, Alexander K.C.
Lam, Joseph M.
Leong, Kin F.
Hon, Kam L.
Barankin, Benjamin
Leung, Amy A.M.
Wong, Alex H.C.
author_facet Leung, Alexander K.C.
Lam, Joseph M.
Leong, Kin F.
Hon, Kam L.
Barankin, Benjamin
Leung, Amy A.M.
Wong, Alex H.C.
author_sort Leung, Alexander K.C.
collection PubMed
description Background: Onychomycosis is a common fungal infection of the nail. Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis. Methods: A PubMed search was completed in Clinical Queries using the key term “onychomycosis”. The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews published within the past 20 years. The search was restricted to English literature. Patents were searched using the key term “onychomycosis” in www.freepatentsonline.com. Results: Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays. Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the management of onychomycosis are also discussed. Conclusion: Oral antifungal therapies are effective, but significant adverse effects limit their use.Although topical antifungal therapies have minimal adverse events, they are less effective than oral antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective and/or alternative treatment modalities for the treatment of onychomycosis which are safer and more effective.
format Online
Article
Text
id pubmed-7509699
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-75096992020-10-09 Onychomycosis: An Updated Review Leung, Alexander K.C. Lam, Joseph M. Leong, Kin F. Hon, Kam L. Barankin, Benjamin Leung, Amy A.M. Wong, Alex H.C. Inflamm Allergy Drug Targets Drug Background: Onychomycosis is a common fungal infection of the nail. Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis. Methods: A PubMed search was completed in Clinical Queries using the key term “onychomycosis”. The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews published within the past 20 years. The search was restricted to English literature. Patents were searched using the key term “onychomycosis” in www.freepatentsonline.com. Results: Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays. Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the management of onychomycosis are also discussed. Conclusion: Oral antifungal therapies are effective, but significant adverse effects limit their use.Although topical antifungal therapies have minimal adverse events, they are less effective than oral antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective and/or alternative treatment modalities for the treatment of onychomycosis which are safer and more effective. Bentham Science Publishers 2020-05 2020-05 /pmc/articles/PMC7509699/ /pubmed/31738146 http://dx.doi.org/10.2174/1872213X13666191026090713 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Drug
Leung, Alexander K.C.
Lam, Joseph M.
Leong, Kin F.
Hon, Kam L.
Barankin, Benjamin
Leung, Amy A.M.
Wong, Alex H.C.
Onychomycosis: An Updated Review
title Onychomycosis: An Updated Review
title_full Onychomycosis: An Updated Review
title_fullStr Onychomycosis: An Updated Review
title_full_unstemmed Onychomycosis: An Updated Review
title_short Onychomycosis: An Updated Review
title_sort onychomycosis: an updated review
topic Drug
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509699/
https://www.ncbi.nlm.nih.gov/pubmed/31738146
http://dx.doi.org/10.2174/1872213X13666191026090713
work_keys_str_mv AT leungalexanderkc onychomycosisanupdatedreview
AT lamjosephm onychomycosisanupdatedreview
AT leongkinf onychomycosisanupdatedreview
AT honkaml onychomycosisanupdatedreview
AT barankinbenjamin onychomycosisanupdatedreview
AT leungamyam onychomycosisanupdatedreview
AT wongalexhc onychomycosisanupdatedreview